The FDA has issued a supplemental proposal mandating that medtech firms include data on pediatric patients when applying for premarket approval or a PMA supplement, a humanitarian device exemption request and a product development protocol. The FDA says it incorporated feedback from a related proposal from 2010 that was later withdrawn. The proposal is up for comment through April 22.
FDA proposal would require pediatric data in submissions
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||